SCHEMBL6155654

SCHEMBL6155654

Cc1cccc(C(=O)NNC(=S)Nc2ccc(Br)c(Cl)c2)c1

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 11/20 0.58
TDP1 Q9NUW8 3/20 0.58
L3MBTL1 Q9Y468 1/20 0.58
ALDH1A1 P00352 12/20 0.58
SMN1; SMN2 Q16637 6/20 0.58
RAB9A P51151 5/20 0.58
GAA P10253 4/20 0.56
PKM P14618 1/20 0.56
LMNA P02545 4/20 0.56
KDM4E B2RXH2 3/20 0.56
HTT P42858 2/20 0.56
MCL1 Q07820 1/20 0.56
POLB P06746 2/20 0.54
MEN1 O00255 4/20 0.53
KMT2A Q03164 4/20 0.53
NPC1 O15118 3/20 0.53
HPGD P15428 1/20 0.52
ALOX12 P18054 1/20 0.52
STAT1 P42224 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5179768 0.84 MAPT (0.75) MAPTTDP1L3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL6662554 0.82 MAPT (0.55) MAPTTDP1L3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL6154317 0.82 MAPT (0.82) MAPTTDP1L3MBTL1ALDH1A1RAB9A
SCHEMBL14096558 0.77 ALDH1A1 (0.69) MAPTTDP1L3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL6155833 0.76 MAPT (0.72) MAPTTDP1ALDH1A1SMN1; SMN2RAB9A
SCHEMBL3644692 0.74 KCNK3 (0.71) MAPTL3MBTL1ALDH1A1RAB9AGAA
SCHEMBL14096573 0.74 ALDH1A1 (0.63) MAPTALDH1A1SMN1; SMN2RAB9ALMNA
SCHEMBL6154649 0.73 MAPT (1.00) MAPTTDP1L3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL4248100 0.73 KCNK3 (0.69) MAPTL3MBTL1ALDH1A1RAB9ALMNA
SCHEMBL24931248 0.73 SMN1; SMN2 (0.89) MAPTALDH1A1SMN1; SMN2RAB9ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases METABASIS THERAPEUTICS, INC. 2005-03-24 US disclosed
EP-1446110-A2 ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES Structural Bioinformatics Inc. (US) 2004-08-18 EP disclosed
WO-2003032916-A2 ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES STRUCTURAL BIOINFORMATICS INC. (US) 2003-04-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases PTPRS, PTPRJ, PTPRCAP MAPT 3318/4885TDP1 219/4885L3MBTL1 279/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.